IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus

IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus

Abstract INTRODUCTION: IgG subclasses involved in the immune response to hepatitis C virus (HCV) antigens have been rarely studied. We investigated the immune response mediated by IgG1 and IgG4 antibodies against the recombinant core and NS3 antigens in patients with chronic hepatitis C. METHODS:...

Full description

Bibliographic Details
Main Authors:	Vanessa Costa dos Santos, Maria Isabel Schinoni, Isabela Silva de Oliveira, Maria Luiza Sousa Atta, Ajax Mercês Atta
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2019-03-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Hepatitis C IgG1 antibodies IgG4 antibodies Core antigen NS3 antigen Viremia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100314&lng=en&tlng=en

Similar Items

IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease
by: Rodrigo V. Motta, et al.
Published: (2024-02-01)

Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies
by: Myrthe E. Sonneveld, et al.
Published: (2018-01-01)

Natural history and pathogenesis of IgG4-related disease
by: Culver, E
Published: (2015)

Exploring the depths of IgG4: insights into autoimmunity and novel treatments
by: Selen Ünlü, et al.
Published: (2024-04-01)

Antileishmanial IgG and IgE antibodies recognize predominantly carbohydrate epitopes of glycosylated antigens in visceral leishmaniasis
by: AM Atta, et al.
Published: (2004-08-01)

Evaluation of VIDAS<sup>®</sup> Diagnostic Assay Prototypes Detecting Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM and IgG Antibodies
by: Somphavanh Somlor, et al.
Published: (2021-07-01)

Plasma antibody levels (IgG1، IgG2) in periodontitis and control groups
by: Mosavi M., et al.
Published: (2009-03-01)

Mycoplasma pneumoniae: IgG and IgM antibody response in presence of different antigens. Evaluation of commercial tests
by: Mariella Tonella, et al.
Published: (2011-12-01)

Immunoglobulin G passive transfer from mothers to infants: total IgG, IgG subclasses and specific antipneumococcal IgG in 6-week Malawian infants exposed or unexposed to HIV
by: Silvia Baroncelli, et al.
Published: (2022-04-01)

Identificación de antígenos de aislamientos colombianos de Giardia duodenalis reconocidos por IgG total y subclases.
by: Jenny Fabiola Hernández, et al.
Published: (2003-09-01)

Dynamics of IgG antibody response against Plasmodium antigens among Nigerian infants and young children
by: Colleen M. Leonard, et al.
Published: (2023-08-01)

Performance of VIDAS<sup>®</sup> Diagnostic Tests for the Automated Detection of Dengue Virus NS1 Antigen and of Anti-Dengue Virus IgM and IgG Antibodies: A Multicentre, International Study
by: Alice F. Versiani, et al.
Published: (2023-03-01)

Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination
by: Tyler W. Hulett, et al.
Published: (2018-04-01)

Avaliação das subclasses IgG1 e IgG3 na doença hemolítica perinatal
by: Maria A. Araújo, et al.
Published: (2003-01-01)

Chlamydial IgG and IgM assessment in patients with non infectious ophthalmic diseases
by: Asadi Amoli F, et al.
Published: (2008-11-01)

Impact of Glycosylation on Effector Functions of Therapeutic IgG
by: Jean-Luc Teillaud, et al.
Published: (2010-01-01)

Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies
by: Cholpon Tilegenova, et al.
Published: (2020-01-01)

Serum total IgG and IgG4 levels in thyroid eye disease
by: Sy A, et al.
Published: (2016-10-01)

Immunoassay for quantification of antigen-specific IgG fucosylation
by: Tonći Šuštić, et al.
Published: (2022-07-01)

Kinetics IgM and IgG SARS-CoV-2 in Recovery patients with Negative Evaluation RT-PCR
by: Jusup Endang, et al.
Published: (2023-11-01)

Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG1–4, IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies
by: Itziar Ubillos, et al.
Published: (2018-06-01)

Plasmodium falciparum and Helminth Coinfections Increase IgE and Parasite-Specific IgG Responses
by: Rebeca Santano, et al.
Published: (2021-12-01)

Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune Functionality
by: Susan H. Tam, et al.
Published: (2017-09-01)

Pitfalls in the Serological Diagnosis of Primary Human Cytomegalovirus Infection in Pregnancy Due to Different Kinetics of IgM Clearance and IgG Avidity Index Maturation
by: Antonella Sarasini, et al.
Published: (2021-02-01)

Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions
by: Pin-Kuang Lai, et al.
Published: (2021-01-01)

Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors
by: Chunhua Luo, et al.
Published: (2021-07-01)

The Blood of the HIV-Infected Patients Contains κ-IgG, λ-IgG, and Bispecific κλ-IgG, Which Possess DNase and Amylolytic Activity
by: Anna Timofeeva, et al.
Published: (2022-02-01)

Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA)
by: Jae Keun Park, et al.
Published: (2022-05-01)

Significance of IgG-Avidity in Antenatal Rubella Diagnosis.
by: Olajide Olubunmi Agbede, et al.
Published: (2013-09-01)

Specific IgG and its subclass antibodies after immunotherapy with gynandropsis gynandra
by: Latha G, et al.
Published: (2005-01-01)

Profile of total IgG, IgG1, IgG2, IgG3 and IgG4 levels in sera of patients with paracoccidioidomycosis: treatment follow-up using Mexo and rPb27 as antigens in an ELISA
by: Lílian da Silva Santos, et al.
Published: (2012-02-01)

Effectiveness of <i>Strongyloides</i> Recombinant IgG Immunoreactive Antigen in Detecting IgG and IgG4 Subclass Antibodies for Diagnosis of Human Strongyloidiasis Using Rapid Immunochromatographic Tests
by: Patcharaporn Boonroumkaew, et al.
Published: (2020-08-01)

Long-Term Follow-Up in IgG4-Related Ophthalmic Disease: Serum IgG4 Levels and Their Clinical Relevance
by: Wei-Yi Chou, et al.
Published: (2022-11-01)

" In vitro Glycation of Human IgG and Its Effect on Interaction with Anti-IgG "
by: Mohammad Taghi Goodarzi, et al.
Published: (2004-12-01)

IgG Anti-IgE Autoantibodies in Visceral Leishmaniasis
by: AM Atta, et al.
Published: (2002-01-01)

Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax
by: Mayara B Barbedo, et al.
Published: (2007-06-01)

IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age
by: Nele Twisselmann, et al.
Published: (2019-01-01)

Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations in vivo
by: Anja Schaffert, et al.
Published: (2020-01-01)

Most of anti-glycolipid IgG-antibodies associated to neurological disorders occur without their IgM counterpart
by: Ricardo Dante Lardone, et al.
Published: (2019-09-01)

The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD
by: Hyun Lee, et al.
Published: (2022-05-01)